Author:
Reddy Teegala Lakshminarayan,Garikapati Koteswara Rao,Reddy S. Gopal,Reddy B. V. Subba,Yadav J. S.,Bhadra Utpal,Bhadra Manika Pal
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Trussardi, A. et al. Sequential overexpression of LRP and MRP but not P-gp 170 in VP16-selected A549 adenocarcinoma cells. Int J Oncol 13, 543–548 (1998).
2. Berger, W. et al. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J Cancer Res Clin Oncol 131, 355–363, 10.1007/s00432-004-0653-9 (2005).
3. Chowdhury, S., Burbridge, S. & Harper, P. G. Chemotherapy for the treatment of hormone-refractory prostate cancer. Int J Clin Pract 61, 2064–2070, 10.1111/j.1742-1241.2007.01551.x (2007).
4. Sun, T. M. et al. Simultaneous Delivery of siRNA and Paclitaxel via a “Two-in-One” Micelleplex Promotes Synergistic Tumor Suppression. Acs Nano 5, 1483–1494, 10.1021/nn103349h (2011).
5. Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G. & Sood, A. K. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11, 59–67, 10.1038/nrc2966 (2011).
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献